Inhibition of ABCB1 overcomes cancer stem cell-like properties and acquired resistance to MET inhibitor in non-small cell lung cancer

被引：0

作者：

Sugano, Teppei ^{[1
]}

Seike, Masahiro ^{[1
]}

Noro, Rintaro ^{[1
]}

Soeno, Chie ^{[1
]}

Nakamichi, Shinji ^{[1
]}

Nishijima, Nobuhiko ^{[1
]}

Matsumoto, Masaru ^{[1
]}

Takeuchi, Susumu ^{[1
]}

Miyanaga, Akihiko ^{[1
]}

Kubota, Kaoru ^{[1
]}

Gemma, Akihiko ^{[1
]}

机构：

[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-756

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

756

引用

页数：2

共 50 条

[31] Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line
Fang, Douglas D.
Cao, Joan
Jani, Jitesh P.
Tsaparikos, Konstantinos
Blasina, Alessandra
Kornmann, Jill
Lira, Maruja E.
Wang, Jianying
Jirout, Zuzana
Bingham, Justin
Zhu, Zhou
Gu, Yin
Los, Gerrit
Hostomsky, Zdenek
VanArsdale, Todd
FRONTIERS OF MEDICINE, 2013, 7 (04) : 462 - 476
[32] Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line
Douglas DFang
Joan Cao
Jitesh PJani
Konstantinos Tsaparikos
Alessandra Blasina
Jill Kornmann
Maruja ELira
Jianying Wang
Zuzana Jirout
Justin Bingham
Zhou Zhu
Yin Gu
Gerrit Los
Zdenek Hostomsky
Todd VanArsdale
Frontiers of Medicine, 2013, 7 (04) : 462 - 476
[33] Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
Zhao, Zhi-Mei
Wang, Song-Ping
Sun, Lei
Ji, You-Xin
CHINESE MEDICAL JOURNAL, 2021, 134 (03) : 373 - 374
[34] SH005S7 Overcomes Primary and Acquired Resistance of Non-Small Cell Lung Cancer by Combined MET/EGFR/HER3 Inhibition
Kang, Sooyeon
Kim, Ji Hye
Hong, Jisoo
Moon, Ji Hong
Kwon, Yun Young
Ko, Seong-Gyu
BIOMED RESEARCH INTERNATIONAL, 2022, 2022
[35] PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer
Thu, Yin Min
Suzawa, Ken
Tomida, Shuta
Ochi, Kosuke
Tsudaka, Shimpei
Takatsu, Fumiaki
Date, Keiichi
Matsuda, Naoki
Iwata, Kazuma
Nakata, Kentaro
Shien, Kazuhiko
Yamamoto, Hiromasa
Okazaki, Mikio
Sugimoto, Seiichiro
Toyooka, Shinichi
PLOS ONE, 2024, 19 (05):
[36] ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
Bo Mi Ku
Jae Yeong Heo
Jinchul Kim
Jong-Mu sun
Se-Hoon Lee
Jin Seok Ahn
Keunchil Park
Myung-Ju Ahn
Investigational New Drugs, 2022, 40 : 265 - 273
[37] Ubiquilin 1 suppresses the cancer stem cell-like traits of non-small cell lung cancer cells by regulating reactive oxygen species homeostasis
Liu, Ting
Ma, Qianqian
Li, Wenjie
Hu, Yan
Yang, Jun
Yao, Qi
BIOENGINEERED, 2021, 12 (01) : 7143 - 7155
[38] Association of ABCB1 polymorphism and erlotinib toxicity with efficacy in patients with non-small cell lung cancer (NSCLC)
Saeki, S.
Sasaki, J.
Hamada, A.
Iwamoto, N.
Inaba, M.
Kishi, H.
Fujii, S.
Ushijima, S.
Semba, H.
Kohrogi, H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[39] JNK Signaling Mediates EPHA2-Dependent Tumor Cell Proliferation, Motility, and Cancer Stem Cell-like Properties in Non-Small Cell Lung Cancer
Song, Wenqiang
Ma, Yufang
Wang, Jialiang
Brantley-Sieders, Dana
Chen, Jin
CANCER RESEARCH, 2014, 74 (09) : 2444 - 2454
[40] Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
Herreros-Pomares, Alejandro
Diego de-Maya-Girones, Juan
Calabuig-Farinas, Silvia
Lucas, Rut
Martinez, Alicia
Miguel Pardo-Sanchez, Jose
Alonso, Sergio
Blasco, Ana
Guijarro, Ricardo
Martorell, Miguel
Escorihuela, Eva
Dolores Chiara, Maria
Durendez, Elena
Gandia, Carolina
Forteza, Jeronimo
Sirera, Rafael
Jantus-Lewintre, Eloisa
Farras, Rosa
Camps, Carlos
CELL DEATH & DISEASE, 2019, 10 (9)

← 1 2 3 4 5 →